Discovery Laboratories Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 8.01 Cr
as on 24-10-2024
- Company Age 21 Year, 9 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 36.42 Cr
as on 24-10-2024
- Satisfied Charges ₹ 27.19 Cr
as on 24-10-2024
- Revenue -29.50%
(FY 2023)
- Profit -3347.20%
(FY 2023)
- Ebitda -74.63%
(FY 2023)
- Net Worth -15.90%
(FY 2023)
- Total Assets 0.74%
(FY 2023)
About Discovery Laboratories
The Corporate was formerly known as Discovery Intermediates Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.01 Cr.
The company currently has active open charges totaling ₹36.42 Cr. The company has closed loans amounting to ₹27.19 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nishita Nadella and Prasanth Manne serve as directors at the Company.
- CIN/LLPIN
U24239TG2003PTC042219
- Company No.
042219
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Discovery Laboratories?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Prasanth Manne | Managing Director | 12-Dec-2003 | Current |
Board Members(1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nishita Nadella | Director | 28-Mar-2009 | Current |
Financial of Discovery Laboratories.
Discovery Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 29.5% decrease. The company also saw a substantial fall in profitability, with a 3347.2% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Discovery Laboratories?
In 2023, Discovery Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Vertus Life Sciences Private LimitedActive 4 years 3 months
Nishita Nadella and Prasanth Manne are mutual person
- Bionsys Life Sciences Private LimitedActive 4 years 30 days
Nishita Nadella and Prasanth Manne are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 31 Dec 2022 | ₹3.25 Cr | Open |
Others Creation Date: 31 Mar 2022 | ₹1.20 Cr | Open |
Others Creation Date: 24 Sep 2021 | ₹5.00 Cr | Open |
How Many Employees Work at Discovery Laboratories?
Unlock and access historical data on people associated with Discovery Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Discovery Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Discovery Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.